News from merck serono A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

04 Nov, 2015, 07:00 GMT Data Confirms Eeva™ Test Fertility Technology Can Improve Embryo Assessment for IVF When Used in Combination With Morphology[1],[2]

Intended for UK based media Data for the Early Embryo Viability Assessment (Eeva™) Test demonstrate that transfer of embryos at Day 3 resulted in...


16 Sep, 2015, 11:00 BST Merck Launches Partnership With Department of Health and Philippine Thyroid Association

Merck Philippines joins forces with Health Department and Thyroid Association to put spotlight on health and wellbeing of Filipino women Merck...


11 Sep, 2015, 09:15 BST Merck to Present New Data at the European Cancer Congress 2015 Reinforcing the Company's Patient-Centric Focus

ECC Abstract #: Avelumab*: 3090, 2749, 2364, 2630, 3110, 2398; Erbitux: 2120, 2112, 420, 2400, 2820; evofosfamide: 2312; tepotinib: 365, 2353, 3082,...


30 Jun, 2015, 08:30 BST Merck Serono Introduces New Eeva Test Version Aiming for Optimized Assisted Reproductive Outcomes

Not intended for US based media Merck Serono continues to provide health care professionals with innovative fertility technologies that aim to...


14 Jun, 2015, 08:15 BST Merck Serono: Innovative Fertility Technologies Gavi and Geri of Partner Genea Biomedx Receive CE Mark

Regulatory clearance allows Gavi automated vitrification instrument and Geri benchtop incubator with camera system to be made available for sale in...


11 Jun, 2015, 08:15 BST Merck Serono Wins Two Red Dot Design Awards 2015 for High Quality Design of Fertility Pens

Not intended for UK or US based media Out of nearly 5,000 entries, Merck Serono won acclaim in the 60th anniversary of the Red Dot Award: Product...


08 Jun, 2015, 12:00 BST Merck, Illumina and Genea Form the Global Fertility Alliance for Excellence in Assisted Reproductive Treatment

Not intended for US based media Global Fertility Alliance will identify and work on improvements of fertility-related laboratory processes Merck, a...


28 May, 2015, 12:00 BST Merck Serono as Pioneer in Assisted Reproductive Treatments Takes Leading Role in Fertility Technologies Signing a Global Collaboration Agreement with Genea Biomedx

Global collaboration to extend the portfolio of Merck Serono, a leading company in fertility treatment, in the growing market of fertility...


26 May, 2015, 06:00 BST Merck Serono Supports 7th International Thyroid Awareness Week to Unmask Hypothyroidism

Hypothyroidism is a disease affecting millions which often goes unrecognized Symptoms of hypothyroidism often mistaken for other diseases Merck...


22 May, 2015, 14:45 BST Merck Serono Announces CHMP Positive Opinion to Extend Kuvan Use to Children with PKU Below 4 Years of Age

Not intended for UK based media CHMP recommendation based on results from the Phase IIIb SPARK study Merck Serono, the biopharmaceutical business of...


15 May, 2015, 08:25 BST Merck to Present Data at ASCO That Illustrate How the Company is Tackling Difficult-to-Treat Cancers

- NOT INTENDED FOR US AND UK BASED MEDIA - ASCO Abstract # Avelumab*: 3023, 3044, 3055, TPS9086, TPS3101, 4042, 4047, 5509, 8034; evofosfamide:...


20 Feb, 2015, 10:30 GMT Merck Serono and Sysmex Inostics Announce First Liquid Biopsy RAS Biomarker Testing Center Opens: Important Milestone for mCRC Patients

Vall d'Hebron, Spain: first hospital to use liquid biopsy RAS biomarker testing technology Leading research center will use technology to evolve...


04 Dec, 2014, 07:30 GMT Merck Serono Awards Grant for Growth - Countdown for Accepting Applications

Merck Serono's Grant for Growth Innovations (GGI) supports innovative projects to advance understanding in the field of growth Closing date for...


27 Sep, 2014, 08:00 BST Merck Serono Awards €1 Million to the Winners of the First Grant for Oncology Innovation

Global winners selected for their unique research projects that have the potential to advance research for the personalized treatment of solid tumors ...


26 Sep, 2014, 07:30 BST Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of 'Precision Medicine in Cancer Care'

Not intended for US- and UK-based media ESMO 2014 Abstract #: Physician biomarker survey: 1080O_PR; Erbitux: CRYSTAL: 541P; LASCCHN: 993PD; DIRECT:...


19 Sep, 2014, 08:30 BST Merck Serono Awards Grant for Growth Innovation (GGI) for the First Time

The first grants awarded to coincide with the 53rd European Society for Paediatric Endocrinology (ESPE) Meeting Investment supports innovative...


03 Sep, 2014, 11:02 BST Merck Announces Detailed 26-Week Results from Phase IIIb Study with Kuvan in Children with PKU Below 4 Years of Age

Not intended for UK based media Detailed 26-week results of SPARK study presented at SSIEM Annual Symposium Phenylalanine tolerance significantly...


27 Aug, 2014, 11:39 BST Merck Serono Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide

Merck Serono is the first and only multinational company in China to dedicate a large scale green-field investment to the production of...


29 Jul, 2014, 07:30 BST Merck Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma

First patient begins treatment in an international Phase II study investigating the efficacy and safety of MSB0010718C in patients with metastatic...


10 Jun, 2014, 12:49 BST Merck Serono Announces FDA Clearance for Auxogyn's Early Embryo Viability Assessment (Eeva®) System

FDA clearance validates Eeva System, which enables in-vitro fertilization (IVF) clinicians to offer the proprietary Eeva Test and further...


02 Jun, 2014, 20:04 BST Merck Serono Launches New Software and Updated Device Designed to Engage People with Multiple Sclerosis

Merck Serono, the biopharmaceutical division of Merck, recognizes World MS Day today, announcing the launch of its updated electronic injection...


29 May, 2014, 07:30 BST Merck Serono to Release New Pipeline Data at ASCO 2014 from Early-Stage Investigational Compounds in Difficult-to-Treat Cancers

ASCO abstract #: Anti-PD-L1: 3064; c-Met: 2521, TPS4151, TPS8121; tecemotide: TPS3658, TPS7608; TH-302: 8534, 2029; further pipeline: 3551, TPS9107,...


26 May, 2014, 07:30 BST Merck Serono Supports 6th International Thyroid Awareness Week

For the 6th time in a row Merck Serono takes part in the International Thyroid Awareness Week with focus on HIGH FIVE Five reasons to be aware of...


17 Apr, 2014, 17:37 BST Merck Serono's President & CEO Belén Garijo has Been Appointed to Board of Directors of L'Oréal

Merck Serono, the biopharmaceutical division of Merck, announced today that Belén Garijo, President & Chief Executive Officer of Merck Serono, has...


07 Apr, 2014, 07:20 BST Merck Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer

 First patient dosed in tecemotide Phase III trial; study recruiting across 250 sites in over 20 countries START2 builds upon the data from the...